Verdict: KEEP

No evidence NFLX underperforms QQQ over the 15-week window. The setup tilts mildly bullish: WBD overhang fully resolved, price increases just deployed, ad revenue doubling, Q1 earnings positioned for beat-and-raise. No identifiable bear catalyst. The market is approximately correct — consensus is bullish and we agree. No edge, no mispricing, no reason to short.

Factor Decomposition

Regression output (250 trading days):

Idiosyncratic variance exceeds the 75% threshold. This is a stock-specific name — returns driven by subscriber trends, content, ad tier, and pricing, not by market or style factors. R-squared 21%.

Critical caveat on beta: The regression shows SPY beta of -0.70, but yfinance reports beta of 1.71 on a longer lookback. The discrepancy is almost certainly an artifact of the WBD acquisition saga contaminating the regression window. In Dec 2025, NFLX sold off 30% on the acquisition announcement while SPY rallied. In Feb 2026, NFLX rallied 14% on the termination while SPY was flat. Both events are resolved and non-recurring. They mechanically drag the SPY coefficient negative without reflecting NFLX's true forward market sensitivity, which is likely 0.8-1.2.

This matters for the basket: the "defensive hedge in risk-off" narrative from the regression is overstated. The real reason to keep NFLX is simpler — no bear thesis exists, not that NFLX hedges QQQ downside.

Financials

FY2025 Actuals (from 8-K Jan 20)

FY2026 Guidance

Margin uplift detail: Original FY2026 guide included $275M of WBD acquisition costs. Deal terminated Feb 27. Of that, ≈$60-100M was already incurred in Q1 (bridge commitment fees for Jan 1-Feb 27 at ≈$60M/month run rate per 8-K). Net savings for FY2026: ≈$175-215M = +0.35pts margin uplift. Netflix has not yet updated guidance.

FCF note: FY2025 FCF of $9.5B was ≈$500M above the $9B guide because a ≈$700M Brazil tax deposit slipped from 2025 to 2026. The $11B FY2026 guide includes this payment. Underlying FCF growth is ≈25% (from ≈$8.8B normalized 2025), better than the headline 16%.

WBD Deal Resolution

The single most important development. WBD terminated the merger agreement Feb 27 after declaring Paramount Skydance's $111B bid a "superior proposal."

What Netflix got:

• $2.8B termination fee (pre-tax cash windfall)
• All committed financing terminated ($42.2B bridge + $20B DDTL + $5B RCF = $67.2B total)
• Buybacks resumed ($8.0B remaining authorization)
• No integration risk, no management distraction, no leverage

What the stock did: Rallied ≈14% on the news but remains ≈30% below its June 2025 high of $134. The acquisition overhang created the entire H2 2025 selloff.

Q1 2026 Earnings Setup (April 16)

Guide: $12.157B revenue / $0.76 EPS. Consensus: $0.77 EPS ($0.01 above guide). Beat cadence: 3 of 4 recent quarters.

Q1 is NOT a clean quarter. GAAP results include: (a) $2.8B termination fee income (other income, not operating), (b) ≈$60-100M bridge commitment fees for Jan 1-Feb 27 (interest expense). Headline EPS will be distorted. Must evaluate on adjusted operating basis. Q2 is the first truly clean quarter.

Tailwinds for an operating beat:

• FX potentially favorable vs Jan 1 baseline
• Price increases partially contributing (rolled out late March)
• Content slate "smoother" vs back-half-weighted 2025
• Citi explicitly expects beat-and-raise

Risk: Q3 2025 was a -15.8% miss on content timing. Content performance is inherently uncertain. But the setup is materially different — the WBD overhang that compressed the stock through Q3 is gone.

Bear Case Examination

Eight potential bear scenarios, none survives scrutiny for the 15-week window:

Valuation: Forward P/E 24.3x is actually below QQQ's ≈30.3x. Trailing P/E (36.9x) is elevated from stock split adjustment and content amortization timing. On forward earnings, not stretched. LR 1.0.

Q1 miss risk: Possible (every stock can miss) but setup is favorable — conservative guide, multiple tailwinds. 20-25% probability of meaningful operating miss. LR 1.2 (mildly bullish).

Pricing backlash / churn: 11% average increase is in-line with history. JPMorgan estimates $1.7B annualized uplift with minimal churn risk. Ad tier provides lower-cost entry at $8.99. Won't be visible in numbers until Q2 reporting. LR 1.0.

Competition: Netflix gaining share (9.0% US TV time, all-time high). The opportunity is cord-cutting from linear TV (40%+ of US TV time), not stealing from streaming peers. No specific competitive catalyst in window. LR 1.0.

FX headwinds: ≈50% international revenue. Dollar has actually weakened modestly since Jan 1 baseline. FX-neutral growth guidance 11-13%. LR 1.0.

Tariff / macro: Netflix is one of the most insulated names in QQQ — subscription business, digital delivery, no supply chain, no tariffs. Gained subscribers during 2008-2009 recession and COVID. In a downturn, cheap entertainment option ($8.99-$26.99/month). LR 1.3 (mildly bullish — macro actually favors NFLX over QQQ).

Regulatory: No pending actions against Netflix. WBD deal termination removes antitrust scrutiny vector. No catalyst in window. LR 1.0.

Content pipeline gaps: Possible but not identifiable in advance. Netflix has deepest pipeline in streaming. "Smoother seasonality" in 2026 per management. LR 1.0.

Bull Case

WBD resolution (LR 1.8): Overhang fully removed. $2.8B cash windfall. Clean balance sheet. Buybacks resumed. Stock still 30% below June high — further normalization likely.

Revenue tailwinds (LR 1.4): Price increases ($1.7B annualized per JPMorgan) + ad revenue doubling ($1.5B to ≈$3B). Combined ≈$4.7B incremental revenue growth, accounting for most of guided $5.5-6.5B increase. Dual engine reduces dependence on subscriber growth alone.

Macro insulation (LR 1.3): Subscription model, no tariff exposure, recession-resistant entertainment. In risk-off environment, NFLX should outperform QQQ on relative basis.

Buyback resumption (LR 1.2): $9.1B repurchased in FY2025. $8.0B remaining authorization. At current price, share reduction supports EPS growth.

Combined LR ≈3.3 (treating WBD cluster as one signal, revenue tailwinds as independent, macro positioning as independent). Moderately bullish. Not strong enough to warrant an active long, but certainly not a remove candidate.

Market Consensus

Sell-Side

37 Buy / 12 Hold / 1 Sell (74% bullish). Mean target $113.21 (+21%). Recent upgrades clustered post-WBD termination: JPM Neutral to Overweight ($120), CFRA Hold to Buy ($115), BofA Buy ($125), Oppenheimer Outperform ($135). One cautious: Rosenblatt Neutral at $95. Consensus is overwhelmingly bullish for the same reasons everyone can read in the 8-K. Edge = 0.

Options Market

Near-term (Apr 17, post-earnings): Implied earnings move ≈9.3% (extracted from term structure: pre-earnings IV 36.1% vs post-earnings 49.4%). P/C ratio 0.94 (neutral). Max pain $90. Call IV trades 2.5pts above put IV — unusual, suggests subtle upside demand. Options market says ≈70% probability stock stays $80-$100 through earnings.

Our window (Jul 17, 110 days): P/C OI 1.21 (bearish) but P/C volume 0.52 (bullish). Legacy put hedges from WBD era remain in the chain while new money buys calls. Call IV trades 5.7pts above put IV — even more unusual at this tenor. Max pain $80. Market-implied median outcome ≈$97 (+3.8%).

The divergence between legacy bearish OI and current bullish flow is the most interesting signal. Those July puts ($75, $70, $80 strikes with 12.8K, 8.3K, 7.3K OI) were almost certainly bought during the WBD saga. The risk they hedged is gone. As they decay or close, positioning shifts bullish.

What's Not Mispriced

The WBD termination, price increases, ad revenue doubling, Q1 setup, and defensive characteristics are all widely known and priced. 50 analysts, $396B market cap. The market is approximately correct. There's no large mispricing — the forward P/E discount to QQQ (24.3x vs 30.3x) is explainable by the WBD trust discount and growth deceleration pricing. Peer comparison (GOOG 25.3x trailing, META 22.4x, MSFT 22.3x) shows NFLX isn't uniquely cheap.

What Would Change the Verdict

• Q1 miss with guide-down (Apr 16): Evidence of fundamental deterioration, not content timing. If adjusted operating miss > 10% with subscriber deceleration commentary, reconsider for FILTER.
• Meaningful churn from price increases: > 5% subscriber loss. Data won't be available until Q2 (July), largely outside our window.
• Ad revenue growth deceleration below doubling trajectory — signals TAM saturation.
• New M&A announcement that brings back leverage/overhang risk.

None anticipated.

Key Dates

Insider Activity

Routine options conversions and pre-planned sales. Hastings (director/founder) sold $39.8M on Mar 2 — consistent with years of selling. CFO Neumann sold ≈$8.2M across three transactions (Feb-Mar). CEO Peters sold $2.3M. No unusual clusters. No buying. LR 1.0 (neutral).